Results 191 to 200 of about 47,543 (305)

Image 4_Quality of life in patients with pan-cancer undergoing concurrent chemoradiotherapy: a bibliometric analysis (1995-2024).tif

Ao Shen (127290), Pan Fan (6173420), Dingrong Fan (17023332), Yidi Wang (3079407), Kailin Tang (831050), Ying Cai (22305), Hengyu Zhou (13651692)   +6 more
openalex   +1 more source

Primary Tracheal Small Cell Carcinoma Treated by Concurrent Chemoradiotherapy [PDF]

, 2016
June Hong Ahn, Jin Hong Chung, Kwan Ho Lee, Kyeong Cheol Shin, Eun Young Choi, Hyun Jung Jin   +5 more
openalex   +1 more source

Tumor Immunotherapy and Microbiome: From Bench‐to‐Bedside Applications

MedComm, Volume 7, Issue 2, February 2026.
The microbiome is related to the efficacy of immunotherapy and can be utilized to predict the efficacy and adverse reactions of immunotherapy. Microbiome‐targeted intervention strategies can improve the efficacy of ICI, but necessitating more comprehensive exploration.
Anqi Lin, Minying Xiong, Aimin Jiang, Li Chen, Lihaoyun Huang, Kailai Li, Hank Z. H. Wong, Jian Zhang, Zaoqu Liu, Quan Cheng, Bufu Tang, Pengpeng Zhang, Peng Luo   +12 more
wiley   +1 more source

Neoadjuvant Concurrent Chemoradiotherapy Versus Neoadjuvant Chemotherapy in Thymic Epithelial Tumors: A Propensity Score-Matched Analysis. [PDF]

Cancers (Basel)
Na B, Kang CH, Yun T, Park JH, Na KJ, Park S, Lee HJ, Park IK, Kim YT, Keam B, Kim HJ.   +10 more
europepmc   +1 more source

Single-arm confirmatory trial of postoperative concurrent chemoradiotherapy using intensity modulated radiation therapy for patients with high-risk uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402) [PDF]

, 2019
Naoya Murakami, Fumiaki Isohashi, Yoko Hasumi, Takahiro Kasamatsu, Hiroyuki Okamoto, Kenichi Nakamura, Taro Shibata, Yoshinori Ito, Satoshi Ishikura, Yasumasa Nishimura, Nobuo Yaegashi, Takafumi Toita   +11 more
openalex   +1 more source

Natural Products in Cancer Prevention and Therapy: Current Challenges and Future Directions

MedComm, Volume 7, Issue 2, February 2026.
Natural products play a pivotal role in cancer therapy. They induce cancer cell death by reprogramming four metabolic pathways while precisely targeting the tumor microenvironment and immune cells. These compounds not only leverage novel delivery systems for innovative applications but also demonstrate unique therapeutic efficacy across clinical stages:
Ruimiao Qian, Jun Ge, Ni Fan, Zheng Sun, Chengcheng Zhao, Yujiao Sun, Yingpeng Li, Yunfei Li, Hui Fu   +8 more
wiley   +1 more source

Sarcopenia following concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma. [PDF]

J Gastrointest Oncol
Vongcharoenpol T, Chaochankit W, Ruangsin S, Laohawiriyakamol S, Leelakiatpaiboon S, Ina N, Kittichet R, Sunpaweravong P, Sunpaweravong S.   +8 more
europepmc   +1 more source

Estimation of prevalence of pretreatment renal insufficiency and use of mathematical formulae to assess the renal dysfunction in patients of head and neck cancers undergoing concurrent chemoradiotherapy in Northern India

, 2016
Punita Lal, Pramod Gupta, Pavan Kumar, Sukanta Barai, Narayan Prasad, Suruchi Jain, Shalini Singh, Sanjay Gambhir, Shaleen Kumar   +8 more
openalex   +1 more source

Long-term Outcomes of Cervical Adenocarcinoma Treated With Concurrent Chemoradiotherapy Using Paclitaxel and Cisplatin [PDF]

, 2020
Yoshihisa Arakaki, Takuro Ariga, Joichi Heianna, Yuko Shimoji, Tadaharu Nakasone, Yusuke Taira, Tomoko Nakamoto, Takuma Ooyama, Wataru Kudaka, Itomi Kaneshima, Kumiko Nishihira, Keiko Mekaru, Yoichi Aoki   +12 more
openalex   +1 more source

Inflammation and Cancer: Molecular Mechanisms and Therapeutic Targets

MedComm, Volume 7, Issue 2, February 2026.
Chronic inflammation fuels tumorigenesis via “internal drivers” and “external attractions.” Targeting these core mechanisms with combined therapies/novel deliveries enables precise, potent anti‐inflammatory–antitumor treatment. ABSTRACT Inflammation is a core pathological factor regulating tumor initiation, progression, and therapeutic resistance, and ...
Xiaodie Liu, Ziyuan Wang, Huirong Zhu, Yicun Han, Qing Ji   +4 more
wiley   +1 more source